Luxembourg - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Luxembourg Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 12.9% year on year. In 2019, the country was number 304 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 1 Cases. India topped the ranking with 66,255 Cases in 2019, +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 1.00 |
| 2018 | 1.00 |
| 2017 | 1.00 |
| 2016 | 1.00 |
| 2015 | 0.00 |
Download all data from 2005 to 2019
How does Luxembourg rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 304 |
#304
Federated States of Micronesia
|
1 | 2019 | +0.0 % | +0.0 % | View data | |
| 304 |
#304
Luxembourg
|
1 | 2019 | +0.0 % | -12.9 % | View data | |
| 304 |
#304
Maldives
|
1 | 2019 | +0.0 % | NA | View data | |